Head and Neck Protocols
As of July 24, 2012 - protocols do open and close daily.
Please check with your physician for additional protocols and/or information.
1. E1305: A Phase III Randomized Trial of Cisplatin & Docetaxel with or without Bevacizumab in Patients with Recurrent or Metastatic Head & Neck Cancer
The purpose of this study is to compare the effects (good and bad) of the addition of a drug called bevacizumab to the standard chemotherapy to see which works better.
2. RTOG 0920: A Phase III Study of Radiation Therapy (IMRT) +/- Cetuximab (C225) for Intermediate Risk Resected Head and Neck Cancer
The purpose of this study is to compare the effects, good and/or bad, of radiation therapy alone with radiation therapy and cetuximab on you and your cancer to find out which is better. In this study, you will get either radiation therapy alone OR radiation therapy and cetuximab.
For more information on these protocols or any other research, please contact your physician or our clinical research coordinator, Jessica Gerlach, CCRP at 845-333-1133
To read more about our Head and Neck Cancer Services and additional Oncology Services, please view our 2011 Oncology Annual Report.